Navigation Links
LifeGen Technologies Awarded NIH Grant to Identify Biomarkers of a Calorie Restricted Diet in Adipose Tissue
Date:10/21/2010

MADISON, Wis., Oct. 21 /PRNewswire/ -- LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.

Caloric restriction is the only dietary intervention proven to increase both maximum and average lifespan in mammals, as well delaying age-related diseases. Because caloric restriction reduces body fat and markers of inflammation related to disease, it is thought that metabolic alterations in fat may underlie many of the health benefits associated with this dietary intervention.  "Several decades of research support the concept of caloric restriction as an effective intervention in aging retardation. This research grant clearly validates the enormous potential of LifeGen's technology in discovering the next generation of anti-aging compounds, based on caloric restriction science," said LifeGen cofounder and Chief Scientific Officer Dr. Tomas A. Prolla.

ABOUT LIFEGEN TECHNOLOGIES, LLC: LifeGen was co-founded in November 2000 by Drs. Richard Weindruch and Tomas A. Prolla, professors at the University of Wisconsin-Madison and leaders in the fields of gerontology and genetics. Drs. Prolla and Weindruch were the first scientists to use DNA microarrays to measure gene activity in mammalian tissues.

LifeGen Technologies is using gene expression technology to study how the aging process is retarded by caloric restriction (CR), the only intervention proven to increase maximum lifespan and retard aging in a diverse array of species. LifeGen has licensed technology from the University of Wisconsin for the use of such "gene expression profiling" as a method to measure the progression of the aging process at the molecular level in individual organs. This technology has been used to identify several "supermarkers" of both aging and caloric restriction, which are currently being used for compound screening.

More information is available at: http://www.lifegentech.com

CONTACT:  Jamie Barger, +1-608-886-6776, Jamie.L.Barger@gmail.com


'/>"/>
SOURCE LifeGen Technologies, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
2. Shrink Nanotechnologies Unveils Product Image of Initial StemDisc450 Prototype
3. Almac Successfully Moves its Clinical Technologies Business Unit Into New North American Headquarters
4. Reportlinker Adds US Forensic Technologies and Services Industry
5. ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial
6. Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIRE™ Label-Free Detection Technology for Proteomics
7. Wireless Health 2010 Explores the Roles of Wireless Technologies in Clinical Services
8. Reportlinker Adds Cancer Profiling and Pathways: Technologies and Global Markets
9. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
10. RF Technologies® Names Mark Harwood New President
11. IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Regular discussions on a range of subjects including policies, debt ... said Poloz. Speaking at a lecture to the ... pointed to the country,s inflation target, which is set by ... "In certain areas there needs to ... goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
Breaking Biology News(10 mins):